Essa Y. Baitei
Riyadh, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial.
Journal: Nature communications
Published: October 11, 2024
A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma.
Journal: Nature communications
Published: October 04, 2023
Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment.
Journal: Nature communications
Published: June 08, 2021
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment.
Journal: Nature communications
Published: September 18, 2020
Mesothelioma: Hippo pathway as a target, lessons from COMMAND.
Journal: Oncotarget
Published: May 16, 2019
Molecular Analysis of Congenital Hypothyroidism in Saudi Arabia: SLC26A7 Mutation Is a Novel Defect in Thyroid Dyshormonogenesis.
Journal: The Journal of clinical endocrinology and metabolism
Published: October 06, 2017
Mutational analysis of PHEX, FGF23 and CLCN5 in patients with hypophosphataemic rickets.
Journal: Clinical endocrinology
Published: January 27, 2017
Cyp24a1 Attenuation Limits Progression of BrafV600E -Induced Papillary Thyroid Cancer Cells and Sensitizes Them to BRAFV600E Inhibitor PLX4720.
Journal: Cancer research
Published: August 02, 2016
IL-12 immunotherapy of Braf(V600E)-induced papillary thyroid cancer in a mouse model.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: March 01, 2015
TSH overcomes Braf(V600E)-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer.
Journal: Oncogene
Published: February 26, 2015
KRAS(G12D)-mediated oncogenic transformation of thyroid follicular cells requires long-term TSH stimulation and is regulated by SPRY1.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: February 18, 2015
Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.
Journal: Thyroid : official journal of the American Thyroid Association
Published: May 07, 2014
Last Updated: 09/26/2026